2022 Conference & Trade Show Schedule

Conference General Session – Ask the Laboratory Experts

Have your top industry questions analyzed and answered! Join us for an exciting Q&A session with our panel of laboratory representatives.

When Bad Things Happen, Be Prepared: Critical Incident Management & Situational Awareness

In the U.S., 2021 had the most mass shootings in history. This presentation focuses on workplace violence, and more importantly, active shooter incidents. Learn how to be trained and aware of how to mitigate and assess risk, and what to do should an event like this take place.
Dan Hanlon, Director of Training Programs Noble Six, Inc.

The Truth About Marijuana Impairment and Recent-Use Detection

Learn the truth about marijuana impairment, how to accurately understand the duration of drug impairment, and the tools employers need in order to select the drug testing methods that accurately meet their needs.
Bill Current, President and Founder, Current Consulting Group

The Science of Addiction: The Role of Drug Testing in Supporting a Recovery Friendly Workplace

This presentation addresses commonly held beliefs and questions about addiction. Gain knowledge about the abundance of employer, community-based, and online resources available for prevention, treatment, and recovery, as well as the many benefits of supporting a comprehensive drug-testing program and Recovery Friendly Workplace.
Ryan West, Director of Corporate Training & Business Development ARCpoint Labs

Combating the Loneliness of Leadership

Leadership can be lonely, especially as a steward of your company’s resources, time, money, and people. Leaders are responsible for making the hard decisions and “The Buck Stops Here.” This presentation will discuss how to be an effective leader and cover 6 ways a leader can combat loneliness.
Chuck Marting, Owner Impairment Detection Academy

Preparing for DOT Audits

A bad audit can end with substantial civil penalties or even a company shut down. We will break down auditing methodology, factors and documents investigators review, and what violations can lead to serious problems, with practical tips to help employers and their TPAs proactively prepare for audits.
Brandon Wiseman, Partner Childress Law, PLLC

DER Difficulties: How to Navigate Challenges and Remain in Compliance

Our panel of expert Designated Employer Representatives (DERs) will be sharing the challenges and compliance issues they face daily such as: What is the best way to handle an untrained TPA? Are collection sites compliant? What if an employer is not supportive of the DER’s management? Bring your questions!
Facilitator: Linda Richardson Panelists: Julie Daugherty, Jackie Emmers, Michelle Steeler, Candy Clepper

Data Security – Don’t Be on The Evening News For The Wrong Reason

How is your donor data protected? Do you have firewalls, VPNs, file encryption, and spam filtering? Is your email safe? What about your website? Are you properly insured to address these risks? We will discuss strategies that will help you keep your business tamper-proof.
Dean Wilson, President Paperless Drug Testing

Reasonable Suspicion Testing – What You Need to know about State Laws

When navigating the fast-changing legal landscape of drug & alcohol testing, one must understand the limitations of state-specific laws and court decisions impacting what is allowable. The role of workplace reasonable suspicion testing is more critical than ever. Employers are cautioned of the differences they may find with state-specific rules.
Nick Hartman, Managing Partner Drug Screening Compliance Institute

Responding to Substance Use Disorder Like Other Medical Conditions

Understanding addiction as a preventable, treatable, chronic brain disease can be challenging for employers. Discover how treating substance use disorder like other chronic medical conditions can impact your business policies, operations and health of your workplace and increase your capacity to recruit and retain a quality workforce.
Karen Pierce, Managing Partner Working Partners Systems, Inc.

Drug and Alcohol Testing Trends: Results of the 24th Annual Drug Testing Industry Survey

The COVID-19 pandemic has had a direct impact on our industry, including how we sell and deliver services. Testing for marijuana, proactively offering oral fluid testing, and adding telehealth collections are among the trends that have gained traction. Additionally, many providers have begun offering COVID testing and vaccination management services.
Join Bill Current, founder of the Current Consulting Group (CCG), as he addresses these issues and more while sharing the results from hundreds of drug testing and background screening insiders. 

Drug Trending of CBD, Designer Marijuana, & Benzodiazepines

Learn about the significant workplace impact of CBD due to contamination, how CBD is used to create designer THC products, and how additional marijuana-related products are being sold to “beat the test”. We will also cover internet-purchased designer benzodiazepines found in pre-employment and post-accident testing and how they are affecting job performance due to their potency.
Dr. David Kuntz, Executive Director for Analytical Toxicology/Laboratory Director Clinical Reference Laboratory

Detecting Fentanyl in Hair and Nail Specimens

Over 800,000 people in the U.S. have perished in the escalating opioid epidemic. The increased use of non-medical fentanyl is a disturbing trend, causing more overdose deaths than heroin, which prompted the DEA to label fentanyl as America’s most dangerous drug. Gain knowledge on testing in hair and nail specimens.
Joseph Jones, Ph.D., NRCC-TC, Chief Operating Officer at United States Drug Testing Laboratory (USDTL)

Ask the DOT: Updates and Q&A Session with Agency Representatives

DOT Agency representatives will present updates and be available to answer your questions.

Employment Drug Testing: Obsolete or More Important Than Ever?

Companies across the country are facing a labor shortage leaving many to ponder if employment drug testing is still relevant. Join us as we take a look at our country’s drug culture and how proper testing and intervention can help increase safety and retain employees in this changing world.
Ruth Bowdish, Managing Director On Demand Occupational Medicine

State Affiliates Meeting

The state affiliate caucus meeting will be held for all official state affiliate and associate affiliate designated representatives. State-related issues will be discussed, including certification and training opportunities, membership recruitment, state governmental advocacy and the responsibilities of a state affiliate representative also known as NDASA “ambassadors”.

Members Meeting

Members will receive an annual State of the Association report from our Chairman, hear what’s on the horizon for NDASA and have the opportunity to ask questions, make suggestions and provide feedback at the annual member’s meeting.

ODAPC Overview

Patrice M. Kelly JD, Office of Drug and Alcohol Policy and Compliance

Special Guest Speaker

Inspiring words from Dan Schneider, the unassuming star of the popular hit Netflix docuseries “The Pharmacist”. When Dan’s son was targeted and killed in a drug deal gone bad, it seemed no one cared. Dan began his own investigation which eventually led to the conviction of the perpetrator and the discovery of one of the nation’s largest pill mills. Through tireless efforts and sharing his personal story, Dan inspires others to face the opioid epidemic head on.

FMCSA Clearinghouse: Stay Current with Changes & FMCSA Part 382 Overview

This past year has seen many changes to the Clearinghouse. Are you up to date? Learn what’s new, what’s working well and what challenges the administrators are working to overcome as we explore all things Clearinghouse! Also presented during this session will be an overview of FMCSA Part 382 from the newly appointed Drug and Alcohol Program Manager.
Gian Marshall, Drug and Alcohol Clearinghouse Program Manager & Crystal Williams, Drug and Alcohol Program Manager FMCSA

Conference Closing